Literature DB >> 10415433

Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.

P C Turner1, P Nikiema, C P Wild.   

Abstract

Fumonisins, fungal toxins produced by Fusarium moniliforme, contaminate maize based foods and feeds throughout the world. They cause liver and kidney toxicity in animals in addition to leukoencephalomalacia in horses and pulmonary edema in pigs. Fumonisin B(1) is carcinogenic in rats and mice. Ecological studies have linked consumption of fumonisin contaminated maize with oesophageal cancer in human populations in South Africa and China. This review discusses the potential health risks for people exposed to the fumonisins, and describes how mechanistic studies of toxicity in animal models have allowed the development of putative biomarkers of fumonisin exposure at the individual level. The requirements for an applicable biomarker include sample availability as well as a high specificity and sensitivity for the exposure of interest. Most environmental toxic insults involve complex exposures both to other toxins and to infections; these confounding factors need to be considered in assessing both the validity of the biomarker and the exposure-disease associations. Fumonisins can be detected in the urine of animals in feeding studies but the sensitivity of the current methodology means only highly exposed people could be monitored. Mechanistic studies indicate that ceramide synthase, an enzyme involved in sphingolipid synthesis, is one cellular target for fumonisin toxicity and carcinogenicity, and this disruption to sphingolipid metabolism increases the ratio of two sphingoid precursors, sphinganine and sphingosine. The altered ratio has been observed in tissues, serum and urine for a number of animal models suggesting it as a good candidate marker of fumonisin exposure. Despite development of analytical methods to measure this biomarker there have been no studies to date correlating it to fumonisin intake in people. Given the toxic effects of fumonisins in animals and the widespread human exposure, which has been calculated to reach 440 micrograms kg(-1) body weight day(-1) in a population consuming high quantities (460 g day(-1)) of contaminated maize, then the development of biomarkers and their application in epidemiological studies should be a priority for research on these toxins. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415433     DOI: 10.1016/s1383-5742(99)00012-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Reduction of individual or combined toxicity of fumonisin B1 and zearalenone via dietary inclusion of organo-modified nano-montmorillonite in rats.

Authors:  Aziza A El-Nekeety; Ahmed A El-Kady; Khaled G Abdel-Wahhab; Nabila S Hassan; Mosaad A Abdel-Wahhab
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-17       Impact factor: 4.223

2.  Calcium montmorillonite clay reduces urinary biomarkers of fumonisin B₁ exposure in rats and humans.

Authors:  A Robinson; N M Johnson; A Strey; J F Taylor; A Marroquin-Cardona; N J Mitchell; E Afriyie-Gyawu; N A Ankrah; J H Williams; J S Wang; P E Jolly; R J Nachman; T D Phillips
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2012-02-10

3.  Mycotoxins and human disease: a largely ignored global health issue.

Authors:  Christopher P Wild; Yun Yun Gong
Journal:  Carcinogenesis       Date:  2009-10-29       Impact factor: 4.944

4.  Validation of fumonisin biomarkers in F344 rats.

Authors:  Qingsong Cai; Lili Tang; Jia-Sheng Wang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-16       Impact factor: 4.219

Review 5.  Real and perceived risks for mycotoxin contamination in foods and feeds: challenges for food safety control.

Authors:  Dragan R Milićević; Marija Skrinjar; Tatjana Baltić
Journal:  Toxins (Basel)       Date:  2010-04-01       Impact factor: 4.546

6.  Mycotoxin Contamination of Edible Non-Timber Forest Products in Cameroon.

Authors:  Joseph Fovo Djeugap; Sita Ghimire; Immaculate Wanjuki; Anne Muiruri; Jagger Harvey
Journal:  Toxins (Basel)       Date:  2019-07-22       Impact factor: 4.546

Review 7.  Development and Limitations of Exposure Biomarkers to Dietary Contaminants Mycotoxins.

Authors:  Paul C Turner; Jessica A Snyder
Journal:  Toxins (Basel)       Date:  2021-04-28       Impact factor: 4.546

8.  Evaluation of sphingolipids in Wistar rats treated to prolonged and single oral doses of fumonisin b₁.

Authors:  Glória M Direito; Adriana P Almeida; Simone Aquino; Tatiana Alves Dos Reis; Claudia Rodrigues Pozzi; Benedito Corrêa
Journal:  Int J Mol Sci       Date:  2008-12-27       Impact factor: 6.208

9.  Fumonisins, trichothecenes and zearalenone in cereals.

Authors:  Selma Yazar; Gülden Z Omurtag
Journal:  Int J Mol Sci       Date:  2008-10-31       Impact factor: 6.208

10.  Endoscopic and clinicopathological patterns of esophageal cancer in Tanzania: experiences from two tertiary health institutions.

Authors:  Mabula D McHembe; Peter F Rambau; Phillipo L Chalya; Hyasinta Jaka; Mheta Koy; William Mahalu
Journal:  World J Surg Oncol       Date:  2013-10-04       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.